Superworth

NRC Health profit margin NRC

Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.

Net margin, 12 months
4.2%
Operating margin, 12 months
10.5%
Net margin on a year earlier
−8.6 pts
Peer median
20.4%

Over the twelve months to Jun 30, 2026, NRC Health kept 4.2% of its revenue as net profit, with an operating margin of 10.5%.

Five years earlier its net margin was 25.7%.

The median for 3 diagnostics and research stocks of a similar size is 20.4%.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY20258.4%16.4%
FY202417.3%24.6%
FY202320.8%27.0%
FY202221.0%30.7%
FY202125.3%34.0%
FY202028.0%32.0%
FY201925.3%33.6%
FY201825.1%29.5%
FY201719.5%29.1%
FY201618.8%28.5%
FY201517.2%25.8%
FY201418.4%28.6%
FY201316.7%26.8%
FY201217.4%26.3%
FY201115.3%24.7%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY264.2%−8.6 pts10.5%
Q1 FY266.5%−10.6 pts14.1%
Q4 FY258.4%−8.9 pts16.4%
Q3 FY2511.8%−7.0 pts19.8%
Q2 FY2512.8%−7.2 pts19.8%
Q1 FY2517.1%−3.5 pts24.8%
Q4 FY2417.3%−3.5 pts24.6%
Q3 FY2418.8%−0.5 pts25.9%
Q2 FY2420.0%+0.4 pts26.9%
Q1 FY2420.6%+0.4 pts27.0%
Q4 FY2320.8%−0.1 pts27.0%
Q3 FY2319.3%−3.6 pts27.3%

Against its peers

Companies in Medical - Diagnostics & Research nearest NRC Health's size, closest first, today.

CompanyProfit margin
NRCNRC Health4.2%
ICCCImmucell2.6%
CDNACareDx24.2%
VCYTVeracyte20.4%
Peer median20.4%

Where NRC Health ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on NRC Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.